<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Physiology and Pharmacology</title>
<title_fa></title_fa>
<short_title>Physiol Pharmacol</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ppj.phypha.ir</web_url>
<journal_hbi_system_id>32</journal_hbi_system_id>
<journal_hbi_system_user>journal32</journal_hbi_system_user>
<journal_id_issn>24765236</journal_id_issn>
<journal_id_issn_online>24765244</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.22034/phypha</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>(previous ISSN: 17350581)</journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1396</year>
	<month>6</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2017</year>
	<month>9</month>
	<day>1</day>
</pubdate>
<volume>21</volume>
<number>3</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Effect of tempol, a synthetic antioxidant, on renal complications of L-NAME induced preeclampsia in rat</title>
	<subject_fa>Pharmacokinetics/Dynamics</subject_fa>
	<subject>Pharmacokinetics/Dynamics</subject>
	<content_type_fa>Experimental research article</content_type_fa>
	<content_type>Experimental research article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p dir=&quot;ltr&quot; style=&quot;text-align: justify;&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;&lt;b&gt;Introduction: &lt;/b&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;It has been suggested that oxidative stress has a crucial role in the pathophysiology of preeclampsia. In the present study, the effect of tempol, a synthetic antioxidant, on kidney injuries and oxidative stress was investigated in an experimental model of preeclampsia in rats. &lt;span style=&quot;font-size: 12px;&quot;&gt;&lt;b&gt;Methods: &lt;/b&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;Preeclampsia was induced by oral administration of L-NAME to the rats on the day 10 of pregnancy. Animals were randomly divided into six groups (10-15 rats in each group); (I) normal pregnant (II) preeclamptic (III, IV, V) preeclamptic + tempol 20, 60 and 180 mg/kg/day, respectively, (VI) preeclamptic + hydralazine 10 mg/kg/day. Urine levels of sodium, potassium, creatinine, lactate dehydrogenase and 24 h protein, blood levels of creatinine and urea, in addition to malondialdehyde concentration in blood and kidney, as well as histological glomeruli changes were assessed. &lt;span style=&quot;font-size: 12px;&quot;&gt;&lt;b&gt;Results: &lt;/b&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;L-NAME administration caused proteinuria and glomerular pathological changes. Tempol (20 and 60 mg/kg/day) significantly reduced plasma and renal (&lt;/font&gt;&lt;/font&gt;&lt;i&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;P&lt;/font&gt;&lt;/font&gt;&lt;/i&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;&lt;0.001) malondialdehyde levels and proteinuria (the biggest calculated &lt;/font&gt;&lt;/font&gt;&lt;i&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;P&lt;/font&gt;&lt;/font&gt;&lt;/i&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;-value was less than 0.05) in preeclamptic rats. Tempol at the dose of 20 mg/kg/day improved the histological changes in preeclamptic animals, but the dose of 60 mg/kg/day restored histological findings. L-NAME did not change the other measured parameters. Hydralazine and highest dose of tempol (180 mg/kg/day) failed to affect biochemical and histological changes in experimental preeclampsia. &lt;span style=&quot;font-size: 12px;&quot;&gt;&lt;b&gt;Conclusion: &lt;/b&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;Renal complications of experimental preeclampsia such as proteinuria and glomerular injuries can be prevented by tempol. The desired effects of tempol depend on its dose.&lt;/font&gt;&lt;/font&gt;&lt;/span&gt;&lt;/font&gt;&lt;/font&gt;&lt;/span&gt;&lt;/font&gt;&lt;/font&gt;&lt;/span&gt;&lt;/font&gt;&lt;/font&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Tempol, Rats, Preeclampsia, Oxidative Stress, Proteinuria.</keyword>
	<start_page>241</start_page>
	<end_page>250</end_page>
	<web_url>http://ppj.phypha.ir/browse.php?a_code=A-10-984-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Mohammad Sharif</first_name>
	<middle_name></middle_name>
	<last_name>Talebianpoor</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>m.talebianpoor @yums.ac.ir</email>
	<code>3200319475328460018193</code>
	<orcid>3200319475328460018193</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Herbal Medicine Research Center, School of Medicine, Yasouj University of Medical Sciences, Yasouj, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Seyed Mohammad</first_name>
	<middle_name></middle_name>
	<last_name>Owji</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>smowji@sums.ac.ir</email>
	<code>3200319475328460018194</code>
	<orcid>3200319475328460018194</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Pathology, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mohsen</first_name>
	<middle_name></middle_name>
	<last_name>Goharinia</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>gohariniam@sums.ac.ir</email>
	<code>3200319475328460018195</code>
	<orcid>3200319475328460018195</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Pharmacology, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Hossein</first_name>
	<middle_name></middle_name>
	<last_name>Mirkhani</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>mirkhan@sums.ac.ir</email>
	<code>3200319475328460018196</code>
	<orcid>3200319475328460018196</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Pharmacology, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
